Satoshi Nishiwada

Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect <i>in vivo</i>

Satoshi Yasuda, Masayuki Sho, Ichiro Yamato et al. · Clinical & Experimental Immunology · 2013 · 281 citations · Full text

Medicine, Oncology, Pharmacology +17

Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer

Satoshi Nishiwada, Masayuki Sho, Satoshi Yasuda et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 180 citations · Full text

Medicine, Cancer Biology, Oncology +12

An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study

Kota Nakamura, Zhongxu Zhu, Eunsung Jun et al. · Gastroenterology · 2022 · 162 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Clinical significance of CD155 expression in human pancreatic cancer.

Satoshi Nishiwada, Masayuki Sho, Satoshi Yasuda et al. · PubMed · 2015 · 143 citations

Medicine, Immunology, Oncology +15

Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients

Masayuki Sho, Yoshiaki Murakami, Fuyuhiko Motoi et al. · Journal of Gastroenterology · 2014 · 76 citations

Medicine, Oncology, Surgery +17